RTI aims to make the first MAPC technology-based implants available for use in orthopedic surgery in early 2012.
Athersys stands to earn another $2 million in development and commercialization milestones and $35.5 million in cumulative revenue milestones, according to the report.
Read the Genetic Engineering and Biotechnology News report on the RTI, Athersy’s deal.
Read other coverage on orthopedic devices:
– Orthopedic Implant Device Can Increase Bone Length
– Top 5 Orthopedic Device Companies Based on 2009 Revenues
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
